B-vitamin status in relation to bone mineral density in treated celiac disease patients

Scandinavian Journal of Gastroenterology

Volumn 50, Issue 8, 2015, Pages 975-984

  Clarke, Michelle ^a   Ward, Mary ^a   Dickey, William ^b   Hoey, Leane ^a   Molloy, Anne M ^c   Waldron, Lisa ^a   Varghese, Abraham ^d   McCann, Adrian ^a   Blayney, Jaine K ^a   McNulty, Helene ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b ALTNAGELVIN HOSPITAL   (United Kingdom)

^c TRINITY COLLEGE DUBLIN   (Ireland)

^d NORTHERN HEALTH AND SOCIAL CARE TRUST   (United Kingdom)

Author keywords

Bone; Celiac disease; Osteoporosis; Vitamin B; Vitamin B12

Indexed keywords

25 HYDROXYVITAMIN D; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE; RIBOFLAVIN; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; VITAMIN B COMPLEX; VITAMIN D;

ADULT; AGED; ARTICLE; BODY WEIGHT; BONE DENSITY; CELIAC DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OSTEOPOROSIS; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; BLOOD; COMPLICATION; DIETARY REFERENCE INTAKE; DRUG EFFECTS; IRELAND; LUMBAR VERTEBRA; MIDDLE AGED; PHOTON ABSORPTIOMETRY; RADIOGRAPHY; SEX DIFFERENCE; YOUNG ADULT;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; BIOMARKERS; BONE DENSITY; CELIAC DISEASE; FEMALE; FOLIC ACID; HUMANS; IRELAND; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOPOROSIS; RECOMMENDED DIETARY ALLOWANCES; SEX FACTORS; VITAMIN B 12; VITAMIN B COMPLEX; VITAMIN D; YOUNG ADULT;

EID: 84929936327     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2015.1015603     Document Type: Article

References (56)

1. Howard MR, Turnbull AJ, Morley P Hollier P, Webb R, Clarke A. A prospective study of the prevalence of undiagnosed celiac disease in laboratory defined iron and folate deficiency. J Clin Pathol 2002;55:754-7.
2. Dickey W. Low serum vitamin B12 is common in celiac disease and is not due to autoimmune gastritis. Eur J Gastroenterol Hepatol 2002;14:425-7.
3. Larussa T, Suraci E, Nazionale I, Abenavoli L, Imeneo M, Luzza F. Bone Mineralization in Celiac Disease. Gastroenterol Res Pract 2012;2012:198025.
4. Peck WA, Burckhardt P, Christiansen C, Fleisch HA, Genant HK, Gennari C, et al. Consensus development conference-diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993;94:646-50.
5. Clarke M, Ward M, Strain JJ, Hoey L, Dickey W, McNulty H. B-vitamins and bone in health and disease: the current evidence. Proc Nutr Soc 2014;73:330-9.
6. Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: metaanalysis of randomised trials. BMJ 1998;316:894-8.
7. McKinley MC, McNulty H, McPartlin J, Strain JJ, Pentieva K, Ward M, et al. Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete. Am J Clin Nutr 2001;73:759-64.
8. McNulty H, Doweyle RC, Strain JJ, Dunne A, Ward M, Molloy AM, et al. Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C->T polymorphism. Circulation 2006;113:74-80.
9. McNulty H, Scott JM. Intake and status of folate and related B-vitamins: considerations and challenges in achieving optimal status. Br J Nutr 2008;99:S48-54.
10. Mudd S, Skovby F, Levy H, Pettigrew K, Wilcken B, Pyeritz R, et al. The natural-history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 1985;37:1-31.
11. Gjesdal CG, Vollset SE, Ueland PM, Refsum H, Drevon CA, Gjessing HK, et al. Plasma total homocysteine level and bone mineral density: the Hordaland Homocysteine Study. Arch Intern Med 2006;166:88-94.
12. Kim B, Koh J, Ahn SH, Lee SH, Kim EH, Bae SJ, et al. High serum total homocysteine levels accelerate hip bone loss in healthy premenopausal women and men. Bone 2013;52: 56-62.
13. McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, et al. Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 2004; 350:2042-9.
14. van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, van der Klift M, de Jonge R, Lindemans J, et al. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 2004;350:2033-41.
15. Gjesdal C, Voliset S, Ueland P, Refsum H, Meyer H, Tell G. Plasma homocysteine, folate, and vitamin B sub(12) and the risk of hip fracture: the hordaland homocysteine study. J Bone Miner Res 2007;22:747-56.
16. Yang J, Hu X, Zhang Q, Cao H, Wang J, Liu B. Homocysteine level and risk of fracture: A meta-analysis and systematic review. Bone 2012;51:376-82.
17. McLean RR, Jacques PF, Selhub J, Fredman L, Tucker KL, Samelson EJ, et al. Plasma B Vitamins, homocysteine, and their relation with bone loss and hip fracture in elderly men and women. J Clin Endocrinol Metab 2008;93: 2206-12.
18. Morris M, Jacques P, Selhub J. Relation between homocysteine and B-vitamin status indicators and bone mineral density in older Americans. Bone 2005;37:234-42.
19. Wang H, Liu C. Association of MTHFR C667T polymorphism with bone mineral density and fracture risk: an updated meta-analysis. Osteoporosis Int 2012;23: 2625-34.
20. Dickey W, Ward M, Whittle CR, Kelly MT, Pentieva K, Horigan G, et al. Homocysteine and related B-vitamin status in celiac disease: Effects of gluten exclusion and histological recovery. Scand J Gastroenterol 2008;43:682-8.
21. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO study group. World Health Organ Tech Rep 1994;843:1-129.
22. Leino A. Fully automated measurement of total homocysteine in plasma and serum on the Abbott IMx analyzer. Clin Chem 1999;45:569-71.
23. Molloy AM, Scott JM. Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method. Meth Enzymol 1997;281:43-53.
24. Kelleher BP, Broin SD. Microbiological assay for vitamin B12 performed in 96-well microtitre plates. J Clin Pathol 1991;44:592-5.
25. Powers HJ, Bates CJ, Prentice AM, Lamb WH, Jepson M, Bowman H. The relative effectiveness of iron and iron with riboflavin in correcting a microcytic anaemia in men and children in rural gambia. Hum Nutr Clin Nutr 1983;37: 413-25.
26. Department of Health. 'National diet and nutrition survey'. In Bates B, Lennox A, Prentice A, Bates C, Swan G, Editors. Headline results from Years 1, 2 and 3 (combined) of the rolling programme (2008/2009-2010/11). England, UK: Public Health England Publications; 2011.
27. Bates CJ, Pentieva KD, Matthews N, Macdonald A. A simple, sensitive and reproducible assay for pyridoxal 5'-phosphate and 4-pyridoxic acid in human plasma. Clin Chim Acta 1999;280:101-11.
28. Hoey L, McNulty H, Askin N, Dunne A, Ward M, Pentieva K, et al. Effect of a voluntary food fortification policy on folate, related B vitamin status, and homocysteine in healthy adults. Am J Clin Nutr 2007;86:1405-13.
29. Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington DC: National Academies Press; 2010. Available from: http://www.iom.edu/Reports/2010/Dietary-Reference-Intakes-for-Calcium-and-Vitamin-D.aspx.
30. Department of Health. Report of the panel on dietary reference values. Report on health and social subjects 41: dietary reference values for food energy and nutrients for the United Kingdom. London, United Kingdom: Her Majesty's Stationery Office; 1991.
31. Malinow M, Bostom A, Krauss R. Homocyst(e)ine, diet, and cardiovascular diseases-A statement for healthcare professionals from the nutrition committee, american heart association. Circulation 1999;99:178-82.
32. Cohen J. Multiple regression and correlation analysis. Statistical power analysis for the behavioral sciences. 2nd edition. Hillsdale, NJ: Lawrence Erlbaum; 1988.
33. Tucker KL, Hannan MT, Qiao N, Jacques PF, Selhub J, Cupples LA, et al. Low plasma vitamin B12 is associated with lower BMD: the Framingham Osteoporosis Study. J Bone Miner Res 2005;20:152-8.
34. Stone KL, Bauer DC, Sellmeyer D, Cummings SR, Low serum vitamin B-12 Levels are associated with increased hip bone loss in older women: A prospective study. J Clin Endocrinol Metab 2004;89:1217-21.
35. Naharci I, Bozoglu E, Karadurmus N, Emer O, Kocak N, Kilic S, et al. Vitamin B12 and folic acid levels as therapeutic target in preserving bone mineral density (BMD) of older men. Arch Gerontol Geriatr 2012;54:469-72.
36. Merriman NA, Putt ME, Metz DC, Yang Y. Hip fracture risk in patients with a diagnosis of pernicious anemia. Gastroenterology 2010;138:1330-7.
37. Cagnacci A, Baldassari F, Rivolta G, Arangino S, Volpe A. Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women. Bone 2003;33: 956-9.
38. Yazdanpanah N, Uitterlinden AG, Zillikens MC, Jhamai M, Rivadeneira F, Hofman A, et al. Low dietary riboflavin but not folate predicts increased fracture risk in postmenopausal women homozygous for the MTHFR 677 T allele. J Clin Endocrinol Metab 2008;23:86-94.
39. Abrahamsen B, Madsen JS, Tofteng CL, Stilgren L, Bladbjerg EM, Kristensen SR, et al. Are effects of MTHFR (C677T) genotype on BMD confined to women with low folate and riboflavin intake? Analysis of food records from the Danish osteoporosis prevention study. Bone 2005;36:577-83.
40. Haliloglu B, Aksungar FB, Ilter E, Peker H, Akin FT, Mutlu N, et al. Relationship between bone mineral density, bone turnover markers and homocysteine, folate and vitamin B12 levels in postmenopausal women. Arch Gynecol Obstet 2010;281:663-8.
41. Rumbak I, Zizic V, Sokolic L Cvijetic S, Kajfez R, Baric IC. Bone mineral density is not associated with homocysteine level, folate and vitamin B-12 status. Arch Gynecol Obstet 2012;285:991-1000.
42. Sowers M, Jannausch M, McConnell D, Little R, Greendale G, Finkelstein J, et al. Hormone predictors of bone mineral density changes during the menopausal transition. J Clin Endocrinol Metab 2006;91:1261-7.
43. Carmel R, Lau K, Baylink D, Saxena S, Singer F. Cobalamin and osteoblast-specific proteins. N Engl J Med 1988;319: 70-5.
44. Kim GS, Kim CH, Park JY, Lee KU, Park CS. Effects of vitamin B12 on cell proliferation and cellular alkaline phosphatase activity in human bone marrow stromal osteoprogenitor cells and UMR106 osteoblastic cells. Metabolism 1996;45:1443-6.
45. Roman-Garcia P, Quiros-Gonzalez I, Mottram L, Lieben L, Sharan K, Wangwiwatsin A, et al. 12-dependent taurine synthesis regulates growth and bone mass. J Clin Invest 2014; 124:2988-3002.
46. Clemens TL. Vitamin B12 Deficiency and Bone Health. N Engl J Med 2014;371:963-4.
47. Lucock M. Is folic acid the ultimate functional food component for disease prevention? Br Med J 2004;328: 211-14.
48. Vaes BL, Lute C, van der Woning SP, Piek E, Vermeer J, Blom HJ, et al. Inhibition of methylation decreases osteoblast differentiation via a non-DNA-dependent methylation mechanism. Bone 2010;46:514-23.
49. Olmos M, Antelo M, Vazquez H, Smecuol E, Maurino E, Bai JC. Systematic review and meta-analysis of observational studies on the prevalence of fractures in celiac disease. Dig Liver Dis 2008;40:46-53.
50. Bianchi ML. Inflammatory bowel diseases, celiac disease, and bone. Arch Biochem Biophys 2010;503:54-65.
51. Han PD, Burke A, Baldassano RN, Rombeau JL, Lichtenstein GR. Nutrition and Inflammatory Bowel Disease. Gastroenterol Clin North Am 1999;28:423-43.
52. Headstrom PD, Rulyak SJ, Lee SD. Prevalence of and risk factors for vitamin B-12 deficiency in patients with Crohn's disease. Inflamm Bowel Dis 2008;14:217-23.
53. Lam JR, Schneider JL, Zhao W, Corley DA. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B-12 deficiency. JAMA 2013;310:2435-42.
54. Loikas S, Koskinen P, Irjala K, Lopponen M, Isoaho R, Kivela S, et al. Vitamin B12 deficiency in the aged: a-population-based study. Age Ageing 2007;36:177-83.
55. Brundtland G. Burden of musculoskeletal conditions at the start of the new millennium. World Health Organ Tech Rep Ser 2003;919:1-218.
56. Institute of Medicine. Folate. Dietary Reference Intake: Thiamin, Riboflavin, Niacin, VitaminB6, VitaminB12, Pantothenic Acid, Biotin and Choline. WashingtonDC:National Academy Press; 1998. pp 306-56.